This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Kenji Uetsuki: Innovator in Pharmaceutical Preparations
Introduction
Kenji Uetsuki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on drug formulations. His expertise and dedication have led to the development of a unique preparation that enhances the efficacy of medications.
Latest Patents
Uetsuki holds a patent for a "Candesartan cilexetil-containing preparation." This preparation includes candesartan cilexetil and lauromacrogol, with the latter being present at a ratio of 2.4 parts by weight or less concerning 100 parts by weight of the preparation. Additionally, the formulation may contain various pharmacologically acceptable additives, such as diluents, disintegrants, and binders, which contribute to its effectiveness.
Career Highlights
Kenji Uetsuki is associated with Sawai Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a positive impact on patient care through improved medication formulations.
Collaborations
Uetsuki has collaborated with esteemed colleagues, including Yasushi Fukuhara and Masaya Hizaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical industry.
Conclusion
Kenji Uetsuki's contributions to pharmaceutical preparations exemplify the importance of innovation in healthcare. His patent for a candesartan cilexetil-containing preparation showcases his commitment to improving medication efficacy. Uetsuki's work continues to influence the field and enhance patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
